Related Experiment Video
Updated: Jul 27, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Cardiovascular involvement in Epstein-Barr virus infection
Xinying Chen1, Yingying Li2, Lijun Deng1,2
1Department of Pediatrics, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Insights
Cardiovascular complications from Epstein-Barr virus (EBV) infection, including coronary artery issues and myocarditis, are severe but rare. Prompt diagnosis and treatment are crucial for better outcomes in EBV-related heart damage.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Epstein-Barr virus (EBV) infection can lead to uncommon but severe cardiovascular complications.
- These complications, including coronary artery dilation (CAD) and myocarditis, have a poor prognosis if not managed promptly.
- Current understanding and clinical guidance for EBV-associated cardiovascular damage are limited.
Purpose of the Study:
- To synthesize current knowledge on cardiovascular damage associated with EBV infection.
- To provide an overview of the pathogenesis, classification, treatment, and prognosis of these complications.
- To enhance clinical recognition and management of EBV-related cardiovascular issues.
Main Methods:
- Review of existing literature on cardiovascular manifestations of Epstein-Barr virus infection.
- Synthesis of data regarding pathogenesis, clinical presentation, and diagnostic approaches.
- Compilation of current treatment strategies and prognostic factors.
Main Results:
- Cardiovascular involvement in EBV infection presents diverse manifestations like CAD, coronary artery aneurysm (CAA), myocarditis, arrhythmias, and heart failure.
- Untreated cardiovascular damage can progress, leading to significant mortality.
- There is a need for more large-scale data and evidence-based guidelines for effective management.
Conclusions:
- Cardiovascular complications of EBV infection require increased clinical attention due to their severity and potential for poor outcomes.
- Early diagnosis and intervention are key to improving prognosis and reducing mortality.
- This review aims to support clinicians in recognizing and managing these challenging cases.
Abstract:
Cardiovascular involvement is an uncommon but severe complication of Epstein-Barr virus (EBV) infection caused by direct damage and immune injury. Recently, it has drawn increasing attention due to its dismal prognosis. It can manifest in various ways, including coronary artery dilation (CAD), coronary artery aneurysm (CAA), myocarditis, arrhythmias, and heart failure, among others. If not treated promptly, cardiovascular damage can progress over time and even lead to death, which poses a challenge to clinicians. Early diagnosis and treatment can improve the prognosis and reduce mortality. However, there is a lack of reliable large-scale data and evidence-based guidance for the management of cardiovascular damage. Consequently, in this review, we attempt to synthesize the present knowledge of cardiovascular damage associated with EBV and to provide an overview of the pathogenesis, classification, treatment, and prognosis, which may enhance the recognition of cardiovascular complications related to EBV and may be valuable to their clinical management.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis IV: Nursing Management